Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Cetuximab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Merck Serono
    Germany
    		 Merck Serono S. A. 301MF10063 Cetuximab bulk concentrate 2019-09-11 2020-08-05 Zone industriale de l'Auriettaz, Rue de l'Auriette 151, 1170 Aubonne, Switzerland
    26/09/2024 Merck Serono
    Germany
    		 Merck Serono S. A. 305MF10129 Cetuximab bulk concentrate 2023-12-06 2023-12-06 Zone industriale de l'Auriettaz, Rue de l'Auriette 151, 1170 Aubonne, Switzerland